| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.23 | 8e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |